PTCHF

distress 2/10 · well-funded / low risk

$1.600%today-17% from 52w high

puretechhealth.com90 employeesFounded 2015Boston, MABiotechnology

Revenue

pre-revenue

Liquidity

$277M

Runway

3.3 yrs

Shares 1y

Price & events

-7.7% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.0%

-6.1%

-9.3%

-7.7%

-9.8%

-26.6%

-66.7%

-71.5%

All

Overview

Market Cap: $385.97M
Enterprise Value: $133.50M
Volume: 0
52 Week Range: $1.55 – $1.92
Total Shares: 241.68M
Float Shares: 157.27M
% Held by Insiders: 9.92%
% Held by Institutions: 52.80%
Beta: 0.79

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 1

2026-08-27earningsEarningsEarnings releaseyahoo

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 241,684,038 · 1 offerings/1y · 0 PIPEs

2026-05-21424B3offering
2024-11-12SC 13Gstrategic_stake
2024-11-07SC 13G/Astrategic_stake

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified